# Continuous Intraventricular Methotrexate in Treating Patients With Leptomeningeal Disease

> **NCT01438021** · NA · WITHDRAWN · sponsor: **City of Hope Medical Center**

## Conditions studied

- Leptomeningeal Metastases

## Interventions

- **OTHER:** pharmacological study
- **DRUG:** methotrexate

## Key facts

- **NCT ID:** NCT01438021
- **Lead sponsor:** City of Hope Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2012-09
- **Primary completion:** 2013-11
- **Final completion:** —
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Lack of funding
- **Last updated:** 2012-11-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01438021

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01438021, "Continuous Intraventricular Methotrexate in Treating Patients With Leptomeningeal Disease". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01438021. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*